title: Dialogue with patient care organizations.
authors.affiliation: Office of Dietary Supplements, National Institutes of Health Bethesda, MD 20892, USA. CostellB@od.nih.gov
authors.forename: Rebecca
authors.initials: R
authors.lastname: Costello
authors.forename: Joan
authors.initials: J
authors.lastname: Young
authors.forename: Rebecca
authors.initials: R
authors.lastname: Burkholder
authors.forename: Joseph
authors.initials: J
authors.lastname: Cranston
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Ortel
authors.forename: Steven
authors.initials: S
authors.lastname: Dentali
authors.forename: Richard
authors.initials: R
authors.lastname: Cotter
authors.forename: Julie
authors.initials: J
authors.lastname: O'sullivan Maillet
authors.forename: Bruce
authors.initials: B
authors.lastname: Hawkins
authors.forename: W
authors.initials: W
authors.lastname: Craig Hooper
mesh_terms: D003257:Consumer Product Safety; D019587:Dietary Supplements / Q000009:adverse effects*; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D011356:Product Labeling
chemical_list: D005343:Fibrinolytic Agents